Posted in | News | Signal Processing

Successful Launch and Initialization of GPS IIF-5 Satellite Supported by Braxton LADO System

Congratulations to SMC/GP, 2 SOPS and 19 SOPS for their successfully launch and initialization of the GPS IIF-5 satellite. GPS IIF-5 was launched on 20 February 2014 and turned over to 2 SOPS for operations on 5 March 2014. This was the 10th successful launch and initialization using the Launch, Anomaly Resolution, and Disposal Operations (LADO) system.

LADO has performed all the mission planning, commanding and telemetry processing necessary to prepare all GPS satellites for operational use since October 2007. Developed and sustained by Braxton Technologies, LADO was built using Braxton’s ACE Premier™ commercial-off-the-shelf (COTS) product line for spacecraft control, astrodynamics and simulation.

“Braxton is proud to be a key partner on the GPS program,” said Ken O’Neil, Braxton’s President and Chief Operating Officer. “As a small business, we greatly value our partnership with the US Air Force and enjoy quickly delivering innovative capabilities to support the U.S. military and the GPS worldwide user community.”

The GPS IIF-5 replaces the GPS IIA-15 satellite launched in 1994. 19 SOPS will control the GPS IIA-15 using LADO where the spacecraft will be stored as a spare available for reactivation within the x-plane for the remainder of its useful life.

About Braxton Technologies

Braxton Technologies, headquartered in downtown Colorado Springs, is strategically focused on command and control mission systems sustainment, mission unique development, targeted corporate acquisitions, and product research and development for their ACE Premier™ product line of configurable C2 applications, simulators, and certified and accredited cross domain solutions. Braxton Technologies is a subsidiary of Braxton Science & Technology Group

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.